CF
WST icon

Centaurus Financial’s West Pharmaceutical WST Stock Holding History

Centaurus Financial’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-295
Closed -$104K – 861
2023
Q4 		$104K Sell
295
-330
-53% -$117K 0.01% 749
2023
Q3 		$235K Hold
625
– – 0.02% 519
2023
Q2 		$239K Sell
625
-22
-3% -$7.86K 0.02% 518
2023
Q1 		$224K Buy
647
+22
+4% +$6.43K 0.02% 631
2022
Q4 		$147K Buy
+625
New +$148K 0.01% 684
2022
Q3 		– Sell
-397
Closed -$120K – 903
2022
Q2 		$120K Sell
397
-11
-3% -$3.58K 0.01% 753
2022
Q1 		$168K Buy
408
+163
+67% +$63.8K 0.01% 715
2021
Q4 		$115K Buy
+245
New +$105K 0.01% 855

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return